IMV, Wistar Institute Partner to Develop T-cell Immunotherapy Against Cancers with BRAF Mutations
News
IMV announced that it has joined with the Wistar Institute to develop an immunotherapy targeting cancer cells with mutations in the BRAF gene. Such mutations are linked to some types of ... Read more